Selected aspects of OTC sales in a pharmacy and by seller of reserved drugs

Authors

  • Martin Pernica Faculty of Business and Management, Brno University of Technology

Keywords:

OTC medicine, pharmabox, pharmacy, seller of reserved drugs, State Institute for Drug Control

Abstract

Purpose of the article Medical care suffers from a lack of funds, especially for the financing of patient care and salaries. The Czech Republic has ceased payments for medicines that can be dispensed without a prescription. One of the possibilities for higher patient participation is to expand the supply of OTC medicines.

Methodology/methods Logical methods were used to process the paper; in particular, this includes induction and deduction, analysis, synthesis, and comparison. In order to assess the development of the supplies of medicinal products to pharmacies and healthcare facilities in the Czech Republic, the period 2014-2016 was used.

Scientific aim The aim of the paper is to compare the conditions for the sale of a selected range of OTC medicines, which can be sold both in the pharmacy and outside the pharmacy by the sellers of reserved drugs. The comparison will be made for the example of the most common pharmacy with an annual turnover of CZK 5-10 million and the MEDIPOINT sales point.

Findings Sales of OTC medicines outside pharmacies do not have an impact on the financial results of pharmacies. The training costs for each employee of the service station are the only costs associated with the sale of medicines. All kinds of pharmabox are the property of MEDIPOINT Services. A partner, such as a gas station, will receive it free of charge for use with complete service. The pharmacy must employ pharmacists and is therefore burdened with much higher wage costs, is legally responsible for sales, and is forced to sell under a competitive market with a lower mark-up.

Conclusions The state should consider the risks associated with this type of drug sales by very poorly qualified petrol station staff. Risk preparations containing ibuprofen and paracetamol should only be available in a pharmacy.

References

Association of Innovative Pharmaceutical Industry. (2017). Medicines development. Retrieved from http://www.aifp.cz/cs/vyvoj-leku/vyzkum-a-vyvoj/

Bažantová, M. (2017). Statement by the Czech Pharmacy Chamber spokesperson for the sale of pharmaceuticals outside of the pharmacy. [bazantova@lekarnici.cz].

Bond, C., Hannaford, P. (2003). Issues related to monitoring the safety of over-the-counter (OTC) medicines. Drug Safety, 26(15), 1065-1074. Doi: 10.2165/00002018-200326150-00001

Center for Drug Evaluation and Research. (2017). FDA Basics - What are over-the-counter (OTC) drugs and how are they approved? Retrieved from https://www.fda.gov/AboutFDA/Transparency/Basics/ucm194951.htm

Craig, D. G. N., Bates, C. M., Davidson, J. S., Martin, K. G., Hayes, P. C., Simpson, K. J. (2011), Overdose pattern and outcome in paracetamol-induced acute severe hepatotoxicity. British Journal of Clinical Pharmacology, 71, 273-282. Doi: 10.1111/j.1365-2125.2010.03819.x

Cyrrus. (2014). Pharmacy - Sectoral analysis. Retrieved from https://www.cyrrus.cz/uploads/PDF/FARMACIE_analyza_2013_1.pdf

Czech Republic. (1992). Act No. 592/1992 Sb. (Coll.), Act on Insurance premiums for public health insurance. Prague, Czech Republic. Retrieved from https://portal.gov.cz/app/zakony/zakonPar.jsp?idBiblio=40381&nr=592~2F1992&rpp=15#local-content

Czech Republic. (1997). Act No. 48/1997 Sb. (Coll.), Act on Public Health Insurance. Prague, Czech Republic. Retrieved from https://portal.gov.cz/app/zakony/zakonPar.jsp?idBiblio=45178&nr=48~2F1997&rpp=15#local-content

Czech Republic. (2007). Act No. 378/2007 Sb. (Coll.), Act on Pharmaceuticals. Prague, Czech Republic. Retrieved from https://portal.gov.cz/app/zakony/zakonPar.jsp?idBiblio=65289&nr=378~2F2007&rpp=15#local-content

Czech Republic. (2008). Act No. 84/2008 Sb. (Coll.), Decree on Good Pharmaceutical Practice, Closer Conditions for Handling Medicines in Pharmacies, Medical Facilities and Other Medicines Providers and Facilities. Prague, Czech Republic. Retrieved from https://www.zakonyprolidi.cz/cs/2008-84 (15.06.2017)

Czech Republic. (2011). Act No. 372/2011 Sb. (Coll.), Act on Health Services. Prague, Czech Republic. Retrieved from https://portal.gov.cz/app/zakony/zakonPar.jsp?idBiblio=75500&nr=372~2F2011&rpp=15#local-content

Deloitte. (2017). Náklady zaměstnavatele na práci v ČR jsou nejvyšší ve střední Evropě. Retrieved from https://www2.deloitte.com/cz/cs/pages/press/articles/cze-tz-naklady-zamestnavatele-na-praci-v-cr-jsou-nejvyssi-ve-stredni-evrope.html

Edukafarm. (2009). Generická substituce z pohledu lékárníka, nejen u aminopenicilinu. Retrieved from http://www.edukafarm.cz/data/soubory/casopisy/6/16-2009_2.pdf

FaRMIS, s.r.o. (2017). OTC sales through free sale: Number of OTC medicines sold in 2015 and 2016 including their value. [E-mail]

Institute of Health Information and Statistics of the Czech Republic. (2016). Health yearbook of the Czech Republic 2015. Retrieved from http://www.uzis.cz/node/7693

Institute of Health and Vocational Education. (2014). Vyhrazené léčivé přípravky: školící materiál pro Odborný kurz pro prodejce vyhrazených léčivých přípravků pořádaný akreditovaným centrem. Pelhřimov. Institut zdravotního a odborného vzdělávání. ISBN 978-80-260-6055-0.

Knobová, M. (2017). OTC drugs: Specifics of OTC drug sales through dedicated drug dealers. [Personal interview].

Ministry of Finance of the Czech Republic. (2017a). Měsíční pokladní plnění státního rozpočtu v roce 2016. Retrieved from http://www.mfcr.cz/cs/verejny-sektor/statni-rozpocet/plneni-statniho-rozpoctu/2016/mesicni-pokladni-plneni-2016-23847

Ministry of Finance of the Czech Republic. (2017b). Makroekonomická predikce - duben 2017. Retrieved from http://www.mfcr.cz/cs/verejny-sektor/makroekonomika/makroekonomicka-predikce/2017/makroekonomicka-predikce-duben-2017-28211

Ministry of Finance of the Czech Republic. (2017c). Struktura a vývoj státního dluhu. Retrieved from http://www.mfcr.cz/cs/verejny-sektor/rizeni-statniho-dluhu/dluhova-statistika/struktura-a-vyvoj-statniho-dluhu

Ministry of Labour and Social Affairs. (2016). Development of social expenditures by the Ministry of Labor and Social Affairs in 2015. Retrieved from http://www.mpsv.cz/files/clanky/25745/TZ_-_Vyvoj_socialnich_vydaju_MPSV_v_roce_2015.pdf

Pavlíčková, H. (2016). Changes in payments for medicines from public health insurance: Changes in payments for medicines from public health insurance. [E-mail]

Popovič, I. (2016). Total Health Expenditure 2010-2014. Institute of Health Information and Statistics of the Czech Republic. Retrieved from http://www.uzis.cz/rychle-informace/vydaje-na-zdravotnictvi-2010-2014

Svobodník, A., Demlová, R., Pecen, L. (2014). Klinické studie v praxi. Brno: Facta Medica.

Sprinx. (2017). TOP 10 léčivých přípravků v roce 2015 v počtu prodaných balení. Retrieved from http://www.zdravotnickydenik.cz/2016/06/top-10-pripravku-na-ceskem-farmaceutickem-trhu-v-roce-2015/

State Institute for Drug Control. (2017). Kontrola prodejců vyhrazených léčivých přípravků. Retrieved from http://www.sukl.cz/kontrola-prodejcu-vyhrazenych-lecivych-pripravku

Špiřík, O. (2017). Details of drug sales through pharmabox MEDIPONT: Availability and pricing policy. [E-mail].

Všeobecná zdravotní pojištovna ČR. (2017). OTC léky. Retrieved from https://www.vzp.cz/tiskove-centrum/otazky-tydne/otc-leky

World Trade Organisation (2001). Declaration on the TRIPS agreement and public health. Retrieved from https://www.wto.org/english/thewto_e/minist_e/min01_e/mindecl_trips_e.htm

Downloads

Published

2017-10-01

Issue

Section

Section 1: Perspectives of Business and Entrepreneurship Development